AbbVie Inc. logo

ABBV

AbbVie Inc.

$257.12
+0.83%
Last updated 9:08 PM
AbbVie Inc logo

AbbVie Inc

AbbVie Inc is a Biotechnology company listed on NEW YORK STOCK EXCHANGE, INC..

Industry
Biotechnology
Exchange
NEW YORK STOCK EXCHANGE, INC.
Market Cap
$454.4B
P/E Ratio
72.0
Cash on Hand
$5.3B(positive)
Shares Outstanding
1.77B shares
Currency
USD
Visit website →

Earnings (EPS)

QuarterEPS EstimateEPS Actual
Q2 2026$3.68$3.65
Q1 2026$2.65$2.65
Q4 2025$2.71$2.71
Q3 2025$1.81$1.86

Financial Highlights

The basics, explained simply — no finance degree required.

52-Week Range
$190.75 – $267.47

The lowest and highest price this stock has traded at over the past year.

Dividend Yield
4.47%

How much this stock pays you back each year, just for holding it — as a % of the share price.

Profit Margin
9.8%

How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.

Revenue Growth
+10.4%

How much the company's sales grew compared to a year ago.

Volatility (Beta)
0.20

How much this stock tends to swing compared to the overall market. Above 1 means it typically moves more than the market (higher risk, higher potential reward); below 1 means it's historically calmer.

Analyst Insights

Analyst Consensus
Buy

Based on 39 analysts

Next Earnings
Oct 29, 2026

Insider Activity

Recent buys and sells by company executives and directors — publicly disclosed, as required by law.

RAPP EDWARD J
Jun 30, 2026 • $251.64/share
Bought 134
Quaggin Susan E
Jun 30, 2026 • $251.64/share
Bought 62
AUSTIN ROXANNE S
May 8, 2026
Bought 1,118
RAPP EDWARD J
May 8, 2026
Bought 1,118
FALK THOMAS J
May 8, 2026
Bought 1,118
WADDELL FREDERICK H
May 8, 2026
Bought 1,118

Recent News